Beihai Biotech
PrivateLast Round
Series C
Extension
Dec 14, 2023
Total Funding Raised
$42.99M
Momentum
Quiet
No recent growth signals
Company Overview
Beihai Biotech is an innovative biopharmaceutical company based in Zhuhai, China, that focuses on developing novel oncology drugs to address unmet clinical needs. The company has developed proprietary technology platforms, including a Precision Delivery Technology Platform and a Peptide-Drug Conjugate (PDC) platform. Its pipeline includes over 10 differentiated drug candidates, with its core asset, BH009 (BEIZRAY), having received FDA approval. Beihai Biotech has raised significant venture capital funding, including a Series C round in December 2023, to advance its clinical trials and commercialization efforts.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beihai Biotech Comps
Public and private peers based on sector, stage, and business model.
Beihai Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Dec 14, 2023 | ||||
| Series B | Oct 31, 2022 | ||||
| Series A Extension | Jan 6, 2022 | ||||
| Series A | Jul 1, 2021 |
Beihai Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza FOFs | Series B |
| Jinhang Group | Series B |
| Shenzhen Guozhong Venture Capital Management | Series B, Series A Extension, Series A |
| 珠海市人民政府国有资产监督管理委员会 | Series A |
| Yikai Venture Capital | Series A Extension, Series B |
| Shenzhen Yifeng Investment Management Enterprise | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 31, 2022
$27.39M round led by Yikai Venture Capital.
- Jan 6, 2022
Raised Series A Extension round with investors including Shenzhen Guozhong Venture Capital Management.
Beihai Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beihai Biotech's valuation, stock price, and market status.
